Position in ZTS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$122,589,680
+$64,640,669 QoQ
Shares Held
1,037,050
+161.9% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 87.8321199556434.ToString("F0")%
Shared 0.ToString("F0")%
None 12.167880044356588.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JUPITER ASSET MANAGEMENT LTD holds $294,861,529 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (41.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,037,050 | $122,589,680 | |
| 2 | VTRS |
Viatris Inc
|
5,768,153 | $77,927,746 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
3,110,039 | $74,423,232 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,196,371 | $11,389,451 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
592,654 | $8,237,890 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
5,307 | $293,530 |
All Filings in ZTS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,589,680 | 1,037,050 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $57,949,011 | 396,043 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $65,926,770 | 422,743 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,278,426 | 13,838 | Shares | Sole | 2025-05-09 | |
| 2020-09-30 | $242,597 | 1,467 | Shares | Defined | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||